Recombinant NT-PRO-BNP Protein

Name: Recombinant NT-PRO-BNP Protein
Brand: Hainan Medikament Trading Co., Ltd.
Price: 50 USD
Rating: 4.6 (5 reviews)

Human NT-pro-Brain Natriuretic Peptide (NT-proBNP) Recombinant The N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is a 76 amino acid N-terminal fragment of brain natriuretic peptide. Both BNP and NT-proBNP levels in the blood are used for screening, diagnosis of acute congestive heart failure (CHF) and may be useful to establish prognosis in heart failure, as both markers are typically higher in patients with worse outcome.

Get a Quote DOWNLOAD View PDF

Specification Of Recombinant NT-PRO-BNP Protein

Source: E. coli

Format: Purified, Liquid

Purification: >85% pure (SDS-PAGE).

Concentration&Lot: 1 mg/ml (Roche ECLIA)

Buffer: 0.01M PBS, pH 7.5

Preservative: None

Storage & Shelf life: Store at -20℃ for 3 years. Avoid multiple freeze/thaw cycles

Product Inquiry

Latest News & Blog Recombinant Troponin C

What Are the Common Diagnostic Tests for Malaria?
2023/08/08

Malaria is a disease transmitted through mosquito bites in nature. Symptoms include chills, fever, sweating, and anemia. Severe cerebral malaria can be fatal. The four common strains of malarial paras...
Performance Evaluation Indicators for In-Vitro Diagnostic Reagents
2023/07/24

In-vitro diagnostic reagents are important auxiliary means for disease diagnosis and treatment. In addition to optimizing reaction patterns and systems, reasonable performance analysis and evaluation ...
In Vitro Diagnostic Reagents Logistics Quality Control
2023/07/09

To ensure that in vitro diagnostic reagents meet the requirements in terms of circulation and other aspects and to ensure the quality of clinical reagents, requirements have been set for the receipt, ...
Analysis of Common Clinical Verification Issues for In Vitro Diagnostic Reagents
2023/06/24

In vitro diagnostic reagents clinical trials refer to the systematic study of the clinical performance of in vitro diagnostic reagents in their corresponding clinical conditions. They are the last sta...